Search Results

Displaying Results 101-125 of 143 "'DT'"

Feb 03, 2026, 10:14 ET Cango Inc. công bố báo cáo cập nhật hoạt động khai thác và sản lượng Bitcoin tháng 1 năm 2026

thôngCango Inc.Email: [email protected] Christensen AdvisoryĐT: +852 2117 0861Email: 

More news about: Cango Inc.


Feb 03, 2026, 08:00 ET Colonial Heights School District Deploys ZeroEyes AI Gun Detection Technology to Enhance School Safety

Department of Homeland Security (DHS) as a promising anti-terrorism technology and was the first video analytics technology to receive SAFETY Act DT&E Designation.Founded by Navy SEALs and elite technologists, ZeroEyes dispatches accurate and real-time actionable intelligence about the illegal

More news about: ZeroEyes


Feb 02, 2026, 10:14 ET Morphic Medical anuncia la certificación NUB Status One para la terapia con dispositivo endoscópico RESET®

El sistema RESET® está diseñado para proporcionar a los pacientes con obesidad y trastornos metabólicos como la diabetes tipo 2 (DT2) la primera solución endoscópica sin incisión, diseñada para lograr una reducción de peso inmediata y una mejora metabólica.El estatus 1 de NUB

More news about: Morphic Medical


Jan 30, 2026, 01:11 ET DT One Luncurkan Tunz eSIM di Grab Indonesia, Hadirkan Layanan Konektivitas Global secara Instan bagi Wisatawan

mendukung kebutuhan pengguna lintasnegara."DT One membantu berbagai platform digital untuk menghadirkan layanan lintasnegara dengan menghubungkan platform tersebut ke jaringan operator seluler global dan mitra internasional. Melalui teknologi Tunz eSIM, DT One telah mendukung akses data seluler sesuai

More news about: DT One


Jan 27, 2026, 08:00 ET Stonegate Fellowship Deploys ZeroEyes AI Gun Detection and Situational Awareness Technology

Department of Homeland Security (DHS) as a promising anti-terrorism technology and was the first video analytics technology to receive full SAFETY Act DT&E Designation.Founded by Navy SEALs and elite technologists, ZeroEyes dispatches accurate and real-time actionable intelligence about the illegal

More news about: ZeroEyes


Jan 26, 2026, 03:42 ET UROVO Unveils DT630: The Enterprise-grade Smartphone Terminal That Redefines Frontline Mobility at NRF 2026

world-leading provider of industry application solutions, proudly announced the launch of the DT630 Enterprise-grade Smartphone Terminal at NRF 2026. Designed to address the dynamic needs of Logistics, Retail, and Healthcare, the DT630 redefines the AIDC landscape by elegantly combining the sleek, intuitive design

More news about: UROVO


Jan 21, 2026, 20:50 ET Digital Turbine Memilih Sea Yen Ong Sebagai Wakil Presiden Regional Bidang Penjualan di Asia Pasifik

yakni memimpin strategi bisnis dan menjalin kerja sama yang erat dengan berbagai agensi maupun pengiklan untuk mendukung pertumbuhan di pasar.Di DT, Sea Yen akan memimpin tim-tim regional di saat mereka meningkatkan kampanye seluler di Asia Pasifik melalui kemitraan eksklusif antara Digital Turbine

More news about: Digital Turbine, Inc.


Jan 21, 2026, 04:33 ET Digital Turbine bổ nhiệm Sea Yen Ong làm Phó Chủ Tịch Khu Vực, phụ trách Bộ Phận Kinh Doanh, khu vực Châu Á - Thái Bình Dương.

dẫn dắt chiến lược thương mại và hợp tác chặt chẽ với các công ty quảng cáo và nhà quảng cáo để hỗ trợ tăng trưởng trên khắp các thị trường.Tại DT, Sea Yen sẽ dẫn dắt các đội ngũ khu vực mở rộng các chiến dịch di động trên khắp khu vực Châu Á Thái Bình Dương, tận dụng các mối quan hệ đối tác độc

More news about: Digital Turbine, Inc.


Jan 15, 2026, 09:07 ET MediCapture startet aiScope™-Pilotprojekt für Veterinärwissenschaften auf der VMX 2026 isit:

MediCaptures VUEES™ University Edition und auf tragbaren VUEES™ Mobility-Plattformen. (Abkürzung für Veterinary Ultrasound and Endoscopy Education Systems, dt. Veterinärmedizinische Ultraschall- und Endoskopie-Ausbildungssysteme).Medizinische KI leicht gemacht iScope™ ermöglicht die Echtzeit-Objekterkennung,

More news about: MediCapture Inc.


Jan 12, 2026, 03:30 ET Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies

the field. The Company's leading programs include DT-7012, a Treg-depleting anti-CCR8 antibody with competitive properties in Phase I/II trials for solid tumors, DT-9046, a first-in-modality, pre-IND biased PAR2 antagonist in inflammation, and DT-9081, a Phase II-ready EP4 receptor antagonist for solid

More news about: Kainova Therapeutics


Jan 07, 2026, 09:00 ET Socket Mobile Introduces New DuraScan Terminal Line for the iPhone 16e

lighter, slimmer, and easier to carry throughout the day without compromising the speed and reliability they expect from Socket Mobile. With the DT841 and DT862, we are giving mobile professionals a powerful handheld solution that works seamlessly with the Apple ecosystem they already trust. These devices

More news about: Socket Mobile, Inc.


Dec 20, 2025, 13:48 ET ETHGas lança mercado futuro de blocos de Ethereum com US$ 800 milhões em compromissos e rodada de investimentos inicial de US$ 12 milhões liderada pela Polychain Capital

Polychain e com a participação de investidores notáveis, como Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT e Amber Group, além de validadores do Ethereum, block builders e relays. Juntas, essas partes contribuíram com um compromisso inicial de US$ 800 milhões

More news about: ETHGas


Dec 20, 2025, 13:47 ET ETHGas 推出以太坊區塊空間期貨市場,獲 8 億美元承諾資金及 1,200 萬美元種子輪融資,由 Polychain Capital 領投

Polychain 領投,知名投資者包括 Stake Capital、BlueYard Capital、Lafayette Macro Advisors、SIG DT 及 Amber Group,同時參與的還有以太坊驗證者、區塊建設者及中繼服務提供者。這些合作夥伴共同承諾提供 8 億美元的初始資金,用以支持 ETHGas 的市場平台與產品開發。ETHGas 簡介EthGas 是以太坊 (Ethereum) 區塊空間期貨市場。ETHGas

More news about: ETHGas


Dec 20, 2025, 13:43 ET ETHGas estrena el mercado de futuros de blockspace de Ethereum con 800 millones de dólares en compromisos y una ronda de financiación inicial de 12 millones de dólares liderada por Polychain Capital

Polychain y en la que participan inversores destacados como Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT y Amber Group, así como validadores, creadores de bloques y retransmisores de Ethereum. En conjunto, estas partes han aportado un compromiso inicial

More news about: ETHGas


Dec 19, 2025, 22:00 ET ETHGas debuteert Ethereums Blockspace Futures Market met $800 miljoen aan verbintenissen en $12 miljoen seed-ronde onder leiding van Polychain Capital

Polychain en met opmerkelijke investeerders zoals Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT en Amber Group, evenals Ethereum-validatoren, blockbouwers en relays. Samen hebben deze partijen een initiële bijdrage van US $ 800 miljoen geleverd

More news about: ETHGas


Dec 19, 2025, 18:31 ET ETHGas startet den Ethereum-Blockspace-Terminmarkt mit Zusagen in Höhe von 800 Millionen US-Dollar und einer Seed-Runde über 12 Millionen US-Dollar unter Führung von Polychain Capital

Polychain erfolgt und an der sich namhafte Investoren wie Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT und Amber Group sowie Ethereum-Validierer, Block-Builder und Relays beteiligen. Zusammen haben diese Parteien zunächst 800 Millionen US-Dollar an Zusagen

More news about: ETHGas


Dec 19, 2025, 18:27 ET ETHGas lance le marché à terme de la chaîne de blocage d'Ethereum avec 800 millions de dollars d'engagements et un tour de table de 12 millions de dollars mené par Polychain Capital.

Polychain et auquel participent des investisseurs de renom tels que Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT et Amber Group, ainsi que des validateurs, des constructeurs de blocs et des relais Ethereum. Ensemble, ces parties ont pris des engagements d'un montant

More news about: ETHGas


Dec 19, 2025, 08:02 ET ETHGas Debuts Ethereum's Blockspace Futures Market with $800m of Commitments and $12m Seed Round Led by Polychain Capital

Polychain and featuring notable investors such as Stake Capital, BlueYard Capital, Lafayette Macro Advisors, SIG DT and Amber Group, as well as Ethereum validators, block builders and relays. Together, these parties have contributed an initial US$800m

More news about: ETHGas


Dec 16, 2025, 09:15 ET SILICONE IGNITION BOOTS MANY SHAPES, STYLES & COLORS OFFERED

Boots include the 115-degree design which is available in four heat ranges up to 600oF. For high performance GM V8 Engines, styles include DT975-SS, FE-1, CB167-BS, and AB28-BS with the SP98-SS. The firm also makes a full range of standard and custom air-operated booters.ETCO Silicone Ignition

More news about: ETCO Incorporated


Dec 10, 2025, 08:30 ET Christmas Adventure Awaits: Ausom Ignites the Holidays with High-Performance E-Scooters

frame (287 lbs load capacity) ensure stability on any path.Ausom DT2 Pro: Performance ChampionFor peak performance enthusiasts, the DT2 Pro stands alone. Advanced hydraulic disc brakes with E-ABS deliver unmatched

More news about: Ausom Electric Scooter


Dec 04, 2025, 08:37 ET Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

domain with diphtheria toxin (DT) fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis,

More news about: Citius Oncology, Inc.


Dec 01, 2025, 12:00 ET Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

domain with diphtheria toxin (DT) fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis,

More news about: Citius Oncology, Inc.


Nov 25, 2025, 08:00 ET Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting

domain with diphtheria toxin (DT) fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis,

More news about: Citius Oncology, Inc.


Nov 21, 2025, 08:37 ET Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration

domain with diphtheria toxin (DT) fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis,

More news about: Citius Oncology, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.